ONO-5920

· Ono Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ONO-5920, covering 2009-10-05 to 2012-10-11. Get the full timeline:

Most recent: Clinical Trial Update: Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan [Phase 3]